Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma
Clinical trial NCT04714697 · UNKNOWN
Trial details
- NCT number
- NCT04714697
- Sponsor
- Asan Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-02-28
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.